ABL DIAGNOSTICS

Highlights ABL Diagnostics

Equities

ABLD

FR001400AHX6

Market Closed - Euronext Paris Other stock markets 10:30:01 2024-05-14 am EDT			5-day change	1st Jan Change
3.06 ^EUR	0.00%		0.00%	-68.45%

2023	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	Dec. 21	CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	23-07-31	CI
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa	23-03-27	MT
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-01	CI
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons.	22-08-30	CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-20	CI
Advanced Biological Laboratories S.A. agreed to acquire the remaining 3.3% stake in Fauvet-Girel for €0.13 million.	21-10-14	CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million.	21-10-14	CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in Fauvet-Girel from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million.	21-10-14	CI
Fauvet-Girel Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-23	CI
Bernard Krief Consultants SA completed the acquisition of 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family.	19-12-09	CI
Bernard Krief Consultants SA signed an agreement to acquire 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family for €8.1 million.	18-06-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW